Verlinvest, an international, family-backed evergreen investment company, has announced its entry into India’s healthcare sector, with the acquisition of a controlling stake in Ferty9 Fertility Center, a chain of fertility clinics in the Telangana region that was founded by Dr C. Jyothi Budi and her partners in 2013. 

This investment will enable Ferty9 to expand its reach across India and supports the development of new technologies and medical innovations, further strengthening Ferty9's position as a leading fertility clinic chain. By investing around $50 million in the platform, Verlinvest will focus on scaling Ferty9’s footprint, offering, and positive impact nationally.

Verlinvest has partnered with Vinesh Gadhia, who will lead Ferty9 as its Chief Executive Officer and Executive Director of the Board to scale Ferty9’s reach and execute its ambition to acquire more fertility assets through this platform. MGadhia is an industry veteran in India’s fertility sector with over 30 years of experience in building commercial teams and expanding scientific partnerships.

Two senior investors from Verlinvest who led this investment, Shagun Tiwary Shah and Manvitha Janagam, will join Ferty9’s Board of Directors, adding to the ~70% of employees at Ferty9 that are women. 

Verlinvest’s acquisition of a controlling stake in Ferty9 Fertility Centre marks their first foray into the healthcare sector in India, having spent several decades investing in the healthcare sector in Europe. Verlinvest aims to leverage its expertise in backing market-leading consumer focused brands and apply it to the healthcare industry.